Journal
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
Volume 17, Issue 3, Pages 545-+Publisher
W B SAUNDERS CO
DOI: 10.1016/S0891-5520(03)00058-8
Keywords
-
Categories
Ask authors/readers for more resources
The development of increasing drug resistance within the past two decades has caused increased interest in re-evaluating the polymyxin antibiotics as therapeutic options for the treatment of multidrug resistant gram-negative infections. Polymyxins were largely abandoned because of toxicity concerns with the class. Little pharmacokinetic and pharmacodynamic data exist for these antibiotics, however, possibly leading to inappropriate dosing regimens. Susceptibility testing and toxicity of the polymyxins are additional areas of discrepancy This article presents an overview of the many issues concerning the polymyxins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available